|

Flotufolastat F-18 Gallium Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Also known as: (18F)-rhPSMA-7.3, 18F-rhPSMA-7.3, 18FrhPSMA-7.3, F-18-rhPSMA-7.3, Fluorine F 18 Radiohybrid PSMA-7.3 +4 more

Pipeline

Early 1: 1Phase 2: 1

Top Sponsors

  • Northwestern University1
  • Emory University1

Indications

  • Cancer2
  • Biochemically Recurrent Prostate Carcinoma1
  • Prostate Carcinoma1
  • Prostate Adenocarcinoma1

Atlanta, Georgia1 trial

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

Emory University Hospital

Phase 2

Chicago, Illinois1 trial

An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial

Northwestern University

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.